4.5 crores of Fake Pharma Bills Seized In Parwanoo

During a raid, team of joint commissioner of state taxes and excise, south enforcement zone Parwanoo, at a pharmaceutical unit in Barotiwala found fake bills of 4.5 crores. They immediately seized all the fake bills of inward supplies amounting to Rs 4.5 crore. 

Rs. 40 crores of fake bills have been recovered during similar raids on nine other pharma units so far.

Senior spokesperson also shared that they also found cash of Rs 61 lakh and the income tax department was informed. He also added that the department sent 25 notices to other units who are receiving supplies from fake companies. 

He also added that the main supplier of these fake bills was a trading firm which has also been tracked. It’s owner is an employee living in the labour quarters and earning a salary of Rs 15,000 per month. Above Rs 10 crores of total tax evasion in these cases. 

Other such firms supplying fake bills are suspected to be running in the state and investigation in this regard is on. Action against other defaulters would be initiated soon.

Related Posts

  • Pharma
  • April 26, 2025
  • 152 views
Merger of Suven Pharma, Cohance Lifesciences to take effect from May 1

Mumbai:  Suven Pharmaceuticals Limited, a contract development and manufacturing organization (CDMO), has announced that it has received final approval from the Department of Pharmaceuticals (DoP), Ministry of Chemicals and Fertilizers,…

  • Pharma
  • April 26, 2025
  • 117 views
Dr Lal PathLabs Q4 profit rises 81% on volume growth, geographic expansion

India’s largest diagnostics service provider, Dr Lal PathLabs (DLPL), on Friday reported an 81.4 per cent year-on-year (Y-o-Y) increase in consolidated net profit for the March quarter of financial year…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Merger of Suven Pharma, Cohance Lifesciences to take effect from May 1

Merger of Suven Pharma, Cohance Lifesciences to take effect from May 1

Dr Lal PathLabs Q4 profit rises 81% on volume growth, geographic expansion

Dr Lal PathLabs Q4 profit rises 81% on volume growth, geographic expansion

Lupin-led price cut slashes cost of key TB drug pretomanid by 25%

Lupin-led price cut slashes cost of key TB drug pretomanid by 25%

250% rally in one year! Multibagger pharma stock jumps despite stock market crash

250% rally in one year! Multibagger pharma stock jumps despite stock market crash